G&W Laboratories, Inc.

G&W Laboratories, Inc.

G&W Laboratories, Inc.

Overview
Date Founded

1919

Headquarters

301 Helen Street,South Plainfield, NJ 07080-3895

Type of Company

Private

Employees (Worldwide)

900

Industries

Pharmaceuticals
Other Business & Consulting Services
Industrial Machinery & Manufacturing

Company Description

G&W Laboratories, Inc. engages in the manufacturing and marketing pharmaceutical products. It offers generics and Rx products. The company was founded by Carl Greenblatt in 1919 and is headquartered in South Plainfield, NJ.

Contact Data
Trying to get in touch with decision makers at G&W Laboratories, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Senior Vice President, General Counsel

Chief Integration Officer

Chief Strategy Officer

Chief Human Resources Officer

Senior Vice President & Head of Global Supply

Vice President & Head of Corporate Development

Vice President, Sales & Marketing

Vice President of Business Development & Alliance Management

Board of Directors

Chairman at G&W Laboratories, Inc.

Paths to G&W Laboratories, Inc.
Potential Connections via
Relationship Science
You
G&W Laboratories, Inc.
Recent Transactions
Details Hidden

Avista Capital Partners, Cosette Pharmaceuticals, Inc. purchase G&W Laboratories, Inc. /Lincolnton Dosage Manufacturing Plant from G&W Laboratories, Inc.

Details Hidden

Avista Capital Partners purchases Cosette Pharmaceuticals, Inc. from G&W Laboratories, Inc.

Details Hidden

G&W Laboratories, Inc. purchases Teva Pharmaceutical Industries Ltd. /Sellersville Facility from Teva Pharmaceutical Industries Ltd.

Transaction Advisors
Investment Advisor

Advised onAvista Capital Partners purchases Cosette Pharmaceuticals, Inc. from G&W Laboratories, Inc.

Legal Advisor

Advised onAvista Capital Partners purchases Cosette Pharmaceuticals, Inc. from G&W Laboratories, Inc.

Key Stats and Financials As of 2019
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$217M
Political Donations
Suppliers
Liquidia Technologies, Inc. Pharmaceuticals | Morrisville, NC

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by G&W Laboratories, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of G&W Laboratories, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and G&W Laboratories, Inc..